nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCB1—peripheral nervous system neoplasm	0.299	1	CbGaD
Telmisartan—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0769	0.158	CbGbCtD
Telmisartan—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0533	0.11	CbGbCtD
Telmisartan—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0363	0.0747	CbGbCtD
Telmisartan—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0339	0.0697	CbGbCtD
Telmisartan—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0333	0.0684	CbGbCtD
Telmisartan—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0328	0.0675	CbGbCtD
Telmisartan—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0306	0.063	CbGbCtD
Telmisartan—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0301	0.0619	CbGbCtD
Telmisartan—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0277	0.057	CbGbCtD
Telmisartan—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0277	0.057	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0227	0.0467	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0205	0.0422	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0192	0.0395	CbGbCtD
Telmisartan—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0118	0.0243	CbGbCtD
Telmisartan—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.011	0.0227	CbGbCtD
Telmisartan—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0108	0.0223	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0074	0.0152	CbGbCtD
Telmisartan—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00265	0.728	CbGdCrCtD
Telmisartan—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00106	0.0615	CbGpPWpGaD
Telmisartan—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000992	0.273	CbGdCrCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.000855	0.0496	CbGpPWpGaD
Telmisartan—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000837	0.0486	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 trafficking events—NME1—peripheral nervous system neoplasm	0.000808	0.0469	CbGpPWpGaD
Telmisartan—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00071	0.0412	CbGpPWpGaD
Telmisartan—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000617	0.0358	CbGpPWpGaD
Telmisartan—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000609	0.0353	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.000459	0.0266	CbGpPWpGaD
Telmisartan—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000458	0.0266	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.0004	0.0232	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.000315	0.0183	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000314	0.0182	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000297	0.0172	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.00029	0.0168	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000279	0.0162	CbGpPWpGaD
Telmisartan—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000276	0.016	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.000276	0.016	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000263	0.0153	CbGpPWpGaD
Telmisartan—Candesartan—ABCB1—peripheral nervous system neoplasm	0.00026	0.608	CrCbGaD
Telmisartan—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000251	0.0146	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00025	0.0145	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PTPN11—peripheral nervous system neoplasm	0.000219	0.0127	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—ABCB1—peripheral nervous system neoplasm	0.000215	0.0125	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000185	0.0107	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000171	0.00991	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.00017	0.00989	CbGpPWpGaD
Telmisartan—Losartan—ABCB1—peripheral nervous system neoplasm	0.000167	0.392	CrCbGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.000141	0.0082	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000141	0.00818	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000138	0.00803	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000135	0.00784	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000134	0.00781	CbGpPWpGaD
Telmisartan—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000133	0.00772	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000126	0.00729	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000124	0.00719	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000121	0.00702	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000118	0.00686	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000117	0.00679	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000112	0.00652	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	0.000109	0.00633	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.000108	0.00627	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000104	0.00602	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TH—peripheral nervous system neoplasm	9.45e-05	0.00548	CbGpPWpGaD
Telmisartan—Hypotension—Etoposide—peripheral nervous system neoplasm	9.29e-05	0.00048	CcSEcCtD
Telmisartan—Gastritis—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.00048	CcSEcCtD
Telmisartan—Pain—Cisplatin—peripheral nervous system neoplasm	9.28e-05	0.00048	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000478	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	9.21e-05	0.00535	CbGpPWpGaD
Telmisartan—Dysuria—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000474	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	9.14e-05	0.00531	CbGpPWpGaD
Telmisartan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.14e-05	0.000472	CcSEcCtD
Telmisartan—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000472	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.13e-05	0.0053	CbGpPWpGaD
Telmisartan—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000471	CcSEcCtD
Telmisartan—Asthma—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000469	CcSEcCtD
Telmisartan—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000468	CcSEcCtD
Telmisartan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.04e-05	0.000467	CcSEcCtD
Telmisartan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.01e-05	0.000466	CcSEcCtD
Telmisartan—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000464	CcSEcCtD
Telmisartan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.94e-05	0.000462	CcSEcCtD
Telmisartan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.000461	CcSEcCtD
Telmisartan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.86e-05	0.000458	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—MYC—peripheral nervous system neoplasm	8.85e-05	0.00514	CbGpPWpGaD
Telmisartan—Somnolence—Etoposide—peripheral nervous system neoplasm	8.84e-05	0.000457	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000457	CcSEcCtD
Telmisartan—Asthenia—Vincristine—peripheral nervous system neoplasm	8.8e-05	0.000455	CcSEcCtD
Telmisartan—Pneumonia—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000454	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.78e-05	0.0051	CbGpPWpGaD
Telmisartan—Infestation—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000452	CcSEcCtD
Telmisartan—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000452	CcSEcCtD
Telmisartan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.73e-05	0.000451	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000451	CcSEcCtD
Telmisartan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.71e-05	0.00045	CcSEcCtD
Telmisartan—Rash—Dactinomycin—peripheral nervous system neoplasm	8.66e-05	0.000448	CcSEcCtD
Telmisartan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.64e-05	0.000447	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000444	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.58e-05	0.000444	CcSEcCtD
Telmisartan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.58e-05	0.000443	CcSEcCtD
Telmisartan—Fatigue—Etoposide—peripheral nervous system neoplasm	8.57e-05	0.000443	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000443	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	8.51e-05	0.00494	CbGpPWpGaD
Telmisartan—Pain—Etoposide—peripheral nervous system neoplasm	8.5e-05	0.000439	CcSEcCtD
Telmisartan—Constipation—Etoposide—peripheral nervous system neoplasm	8.5e-05	0.000439	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000439	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000439	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000438	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000436	CcSEcCtD
Telmisartan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.42e-05	0.000435	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	8.41e-05	0.00488	CbGpPWpGaD
Telmisartan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.4e-05	0.000434	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000433	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000431	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	8.31e-05	0.00483	CbGpPWpGaD
Telmisartan—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000427	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000426	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000424	CcSEcCtD
Telmisartan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.19e-05	0.000423	CcSEcCtD
Telmisartan—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.16e-05	0.000422	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.00042	CcSEcCtD
Telmisartan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.13e-05	0.00042	CcSEcCtD
Telmisartan—Dizziness—Vincristine—peripheral nervous system neoplasm	8.12e-05	0.000419	CcSEcCtD
Telmisartan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.1e-05	0.000419	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000418	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000418	CcSEcCtD
Telmisartan—Rash—Alitretinoin—peripheral nervous system neoplasm	8.03e-05	0.000415	CcSEcCtD
Telmisartan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.02e-05	0.000415	CcSEcCtD
Telmisartan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.99e-05	0.000413	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000413	CcSEcCtD
Telmisartan—Headache—Alitretinoin—peripheral nervous system neoplasm	7.98e-05	0.000412	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	7.96e-05	0.00462	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	7.96e-05	0.00462	CbGpPWpGaD
Telmisartan—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000411	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.00041	CcSEcCtD
Telmisartan—Urticaria—Etoposide—peripheral nervous system neoplasm	7.9e-05	0.000408	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000406	CcSEcCtD
Telmisartan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.86e-05	0.000406	CcSEcCtD
Telmisartan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.86e-05	0.000406	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000406	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000406	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000403	CcSEcCtD
Telmisartan—Vomiting—Vincristine—peripheral nervous system neoplasm	7.8e-05	0.000403	CcSEcCtD
Telmisartan—PPARG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.79e-05	0.00452	CbGpPWpGaD
Telmisartan—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.000402	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000402	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.0004	CcSEcCtD
Telmisartan—Rash—Vincristine—peripheral nervous system neoplasm	7.74e-05	0.0004	CcSEcCtD
Telmisartan—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.73e-05	0.0004	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	7.73e-05	0.00449	CbGpPWpGaD
Telmisartan—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000399	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000398	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000398	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000397	CcSEcCtD
Telmisartan—Headache—Vincristine—peripheral nervous system neoplasm	7.69e-05	0.000397	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000395	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	7.63e-05	0.00443	CbGpPWpGaD
Telmisartan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000394	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000392	CcSEcCtD
Telmisartan—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.56e-05	0.000391	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000391	CcSEcCtD
Telmisartan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.42e-05	0.000384	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000382	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000379	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.32e-05	0.000379	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.000378	CcSEcCtD
Telmisartan—Nausea—Vincristine—peripheral nervous system neoplasm	7.29e-05	0.000377	CcSEcCtD
Telmisartan—Flushing—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000376	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000376	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000376	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	7.23e-05	0.0042	CbGpPWpGaD
Telmisartan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000373	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000372	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.00037	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.00037	CcSEcCtD
Telmisartan—Asthenia—Etoposide—peripheral nervous system neoplasm	7.13e-05	0.000369	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000369	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000368	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000368	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.000366	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000365	CcSEcCtD
Telmisartan—Chills—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000364	CcSEcCtD
Telmisartan—Pruritus—Etoposide—peripheral nervous system neoplasm	7.03e-05	0.000364	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.01e-05	0.000362	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000362	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	6.93e-05	0.00402	CbGpPWpGaD
Telmisartan—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.9e-05	0.000357	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000355	CcSEcCtD
Telmisartan—Rash—Cisplatin—peripheral nervous system neoplasm	6.84e-05	0.000354	CcSEcCtD
Telmisartan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.84e-05	0.000353	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000353	CcSEcCtD
Telmisartan—Erythema—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000353	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	6.82e-05	0.00396	CbGpPWpGaD
Telmisartan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.8e-05	0.000352	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.78e-05	0.000351	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	6.77e-05	0.00393	CbGpPWpGaD
Telmisartan—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.00035	CcSEcCtD
Telmisartan—PPARG—Gene Expression—EED—peripheral nervous system neoplasm	6.76e-05	0.00393	CbGpPWpGaD
Telmisartan—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000348	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000348	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000348	CcSEcCtD
Telmisartan—Tension—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000346	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000346	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000343	CcSEcCtD
Telmisartan—Back pain—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000341	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.00034	CcSEcCtD
Telmisartan—Dizziness—Etoposide—peripheral nervous system neoplasm	6.57e-05	0.00034	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000339	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000339	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000338	CcSEcCtD
Telmisartan—Chills—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000337	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000335	CcSEcCtD
Telmisartan—Nausea—Cisplatin—peripheral nervous system neoplasm	6.45e-05	0.000333	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000329	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000327	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6.33e-05	0.00367	CbGpPWpGaD
Telmisartan—Vomiting—Etoposide—peripheral nervous system neoplasm	6.32e-05	0.000327	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000327	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000327	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000326	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.28e-05	0.00365	CbGpPWpGaD
Telmisartan—Rash—Etoposide—peripheral nervous system neoplasm	6.27e-05	0.000324	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.26e-05	0.000324	CcSEcCtD
Telmisartan—Headache—Etoposide—peripheral nervous system neoplasm	6.23e-05	0.000322	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000322	CcSEcCtD
Telmisartan—Tension—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.00032	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.00032	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.16e-05	0.00358	CbGpPWpGaD
Telmisartan—Malaise—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000318	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—AKT1—peripheral nervous system neoplasm	6.14e-05	0.00356	CbGpPWpGaD
Telmisartan—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000317	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000317	CcSEcCtD
Telmisartan—Syncope—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000316	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000316	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000314	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000312	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.03e-05	0.0035	CbGpPWpGaD
Telmisartan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6e-05	0.00031	CcSEcCtD
Telmisartan—Cough—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000308	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—NCAM1—peripheral nervous system neoplasm	5.91e-05	0.00343	CbGpPWpGaD
Telmisartan—Nausea—Etoposide—peripheral nervous system neoplasm	5.9e-05	0.000305	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.89e-05	0.000305	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000303	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000302	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.0003	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.0003	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.0003	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000299	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000298	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000297	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000294	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000294	CcSEcCtD
Telmisartan—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.68e-05	0.0033	CbGpPWpGaD
Telmisartan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000293	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000293	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000289	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000288	CcSEcCtD
Telmisartan—Oedema—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000288	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000287	CcSEcCtD
Telmisartan—Infection—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000286	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.54e-05	0.00321	CbGpPWpGaD
Telmisartan—Cough—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000285	CcSEcCtD
Telmisartan—Shock—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000283	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.48e-05	0.00318	CbGpPWpGaD
Telmisartan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000282	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.46e-05	0.00317	CbGpPWpGaD
Telmisartan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000282	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.45e-05	0.000282	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000281	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.00028	CcSEcCtD
Telmisartan—PPARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	5.41e-05	0.00314	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.000278	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000278	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000278	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000278	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000277	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000276	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000275	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.31e-05	0.000275	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000272	CcSEcCtD
Telmisartan—PPARG—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.26e-05	0.00305	CbGpPWpGaD
Telmisartan—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000269	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000267	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000267	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.12e-05	0.00297	CbGpPWpGaD
Telmisartan—Infection—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000265	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000262	CcSEcCtD
Telmisartan—Shock—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000262	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000261	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.06e-05	0.00294	CbGpPWpGaD
Telmisartan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000261	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000261	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.00026	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000259	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000259	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000258	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000257	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000256	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000254	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000254	CcSEcCtD
Telmisartan—PPARG—SREBP signalling—AKT1—peripheral nervous system neoplasm	4.9e-05	0.00284	CbGpPWpGaD
Telmisartan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.00025	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000249	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000249	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000248	CcSEcCtD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.77e-05	0.00277	CbGpPWpGaD
Telmisartan—Pain—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000246	CcSEcCtD
Telmisartan—Constipation—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000246	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000243	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000241	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.65e-05	0.0027	CbGpPWpGaD
Telmisartan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000239	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000238	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000237	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000237	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000236	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000235	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000232	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	4.46e-05	0.00259	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.00023	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.00023	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000229	CcSEcCtD
Telmisartan—Pain—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000228	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000228	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000228	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000228	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.37e-05	0.00254	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	4.27e-05	0.00248	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.27e-05	0.00248	CbGpPWpGaD
Telmisartan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.00022	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000218	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	4.11e-05	0.00239	CbGpPWpGaD
Telmisartan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000212	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	4.1e-05	0.00238	CbGpPWpGaD
Telmisartan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000212	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.09e-05	0.00238	CbGpPWpGaD
Telmisartan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000211	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000211	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000207	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000204	CcSEcCtD
Telmisartan—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.83e-05	0.00223	CbGpPWpGaD
Telmisartan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000197	CcSEcCtD
Telmisartan—PPARG—Metabolism—GNS—peripheral nervous system neoplasm	3.8e-05	0.00221	CbGpPWpGaD
Telmisartan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000196	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.79e-05	0.0022	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.74e-05	0.00217	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.7e-05	0.00215	CbGpPWpGaD
Telmisartan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000191	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.00019	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.67e-05	0.00213	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.66e-05	0.00212	CbGpPWpGaD
Telmisartan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000189	CcSEcCtD
Telmisartan—PPARG—Metabolism—NME1—peripheral nervous system neoplasm	3.65e-05	0.00212	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.58e-05	0.00208	CbGpPWpGaD
Telmisartan—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.000183	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000182	CcSEcCtD
Telmisartan—Rash—Epirubicin—peripheral nervous system neoplasm	3.51e-05	0.000182	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.51e-05	0.000181	CcSEcCtD
Telmisartan—PPARG—Metabolism—COX2—peripheral nervous system neoplasm	3.51e-05	0.00204	CbGpPWpGaD
Telmisartan—Headache—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.00018	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.45e-05	0.002	CbGpPWpGaD
Telmisartan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000176	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.32e-05	0.00193	CbGpPWpGaD
Telmisartan—Nausea—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000171	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000169	CcSEcCtD
Telmisartan—Rash—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000168	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.25e-05	0.00189	CbGpPWpGaD
Telmisartan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000168	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.24e-05	0.00188	CbGpPWpGaD
Telmisartan—Headache—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000167	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.2e-05	0.00186	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.16e-05	0.00183	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.14e-05	0.00183	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.13e-05	0.00182	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.07e-05	0.00178	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000158	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	3e-05	0.00174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.99e-05	0.00173	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.95e-05	0.00171	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.89e-05	0.00168	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.84e-05	0.00165	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	2.82e-05	0.00164	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.77e-05	0.00161	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	2.7e-05	0.00157	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.67e-05	0.00155	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.66e-05	0.00154	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.62e-05	0.00152	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.61e-05	0.00152	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.56e-05	0.00149	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.47e-05	0.00143	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.33e-05	0.00135	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	2.3e-05	0.00134	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.28e-05	0.00132	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	2.28e-05	0.00132	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.24e-05	0.0013	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.18e-05	0.00126	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	2.14e-05	0.00125	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.12e-05	0.00123	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.07e-05	0.0012	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.06e-05	0.0012	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2e-05	0.00116	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.97e-05	0.00115	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	1.95e-05	0.00113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.92e-05	0.00111	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.86e-05	0.00108	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TH—peripheral nervous system neoplasm	1.83e-05	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.83e-05	0.00106	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.77e-05	0.00102	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.75e-05	0.00102	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.74e-05	0.00101	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.72e-05	0.000997	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.68e-05	0.000975	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.68e-05	0.000974	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.58e-05	0.000916	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.57e-05	0.000911	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.56e-05	0.000907	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.55e-05	0.000902	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.54e-05	0.000891	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.5e-05	0.00087	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	1.49e-05	0.000867	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.47e-05	0.000855	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	1.47e-05	0.000851	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.44e-05	0.000834	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.42e-05	0.000824	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.42e-05	0.000823	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.38e-05	0.000803	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.35e-05	0.000786	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.33e-05	0.000775	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.26e-05	0.00073	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.23e-05	0.000716	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.19e-05	0.000689	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.17e-05	0.000677	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.15e-05	0.000667	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.09e-05	0.000632	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.07e-05	0.000621	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000589	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.01e-05	0.000588	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	9.3e-06	0.00054	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.22e-06	0.000535	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.08e-06	0.000527	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.68e-06	0.000504	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.55e-06	0.000496	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.44e-06	0.00049	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.37e-06	0.000486	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.86e-06	0.000456	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.67e-06	0.000445	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.67e-06	0.000445	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.5e-06	0.000435	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	7.48e-06	0.000434	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.39e-06	0.000429	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.32e-06	0.000425	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.21e-06	0.000419	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.01e-06	0.000407	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.53e-06	0.000379	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	6.03e-06	0.00035	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.92e-06	0.000344	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.89e-06	0.000342	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.36e-06	0.000311	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	5.19e-06	0.000301	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.13e-06	0.000298	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	4.73e-06	0.000274	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.53e-06	0.000263	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	4.03e-06	0.000234	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.94e-06	0.000171	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.63e-06	9.45e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	9.23e-05	CbGpPWpGaD
